CompletedNot applicableNCT04755673
Atrantil for Intestinal Bacterial Overgrowth
Studying Overgrowth syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Northwestern University
- Principal Investigator
- Darren Brenner, MDNorthwestern Memorial Hospital/Feinberg School of Medicine
- Intervention
- Atrantil (Medical Food)(other)
- Enrollment
- 40 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2020 – 2022
Study locations (1)
- Northwestern Medicine Digestive Health Center, Chicago, Illinois, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04755673 on ClinicalTrials.govOther trials for Overgrowth syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07145580Combined Lactulose H2-breath Test With Abdominal ImagingKlinik Arlesheim
- RECRUITINGPHASE1, PHASE2NCT06721884Herbal Evaluation Of Artemisia Annua For Small Intestinal Bacterial OvergrowthNational University of Natural Medicine
- RECRUITINGNCT06710067Urine Metabolites in the Diagnosis of DiseaseLuventix, Inc.